Nasus Pharma Ltd. (NSRX)
Market Closed
17 Jul, 20:00
AMEX AMEX Primary $
3. 01
-0.06
-1.9544%
$
25.24M Market Cap
- P/E Ratio
- Div Yield
6,800 Volume
- Eps
$ 3.07
Previous Close Want to track NSRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nasus Pharma Ltd. (NSRX) Statistics
Valuation metrics
Market Cap 25.24M
Enterprise value 25.92M
Trailing P/E (ttm) -17.71
Forward P/E -
PEG ratio -0.18
Price/Sales (ttm) -
Price/Book (mrq) -
Enterprise Value/Revenue -
Enterprise Value/EBITDA -17.02
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 11.47K
Average volume (90 days) 65.65K
Price summary
52-Week low 1.98
52-Week high 9.99
Beta -
50-Day moving average 3.17
200-Day moving average 4.03
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -
Return on equity -
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.17
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) -
Book value per share (mrq) -
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
